Nektar Therapeutics (NASDAQ: NKTR) Have Inclined 133.63% YTD, Forecasting What Will Happen Next
Nektar Therapeutics (NASDAQ:NKTR)’s traded shares stood at 1.06 million during the last session, with the company’s beta value hitting 0.60. At the close of trading,